BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 38574529)

  • 1. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy.
    Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B
    Front Immunol; 2024; 15():1384633. PubMed ID: 38799454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia.
    Yuan J; Zhang J; Zhao B; Liu F; Liu T; Duan Y; Chen Y; Chen X; Zou Y; Zhang L; Guo Y; Yang W; Yang Y; Wei J; Zhu X; Zhang Y
    Cancer Lett; 2024 Jun; 596():217018. PubMed ID: 38844062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMLdb: a comprehensive multi-omics platform to identify biomarkers and drug targets for acute myeloid leukemia.
    Vinod Kumar K; Kumar A; Kundal K; Sengupta A; R K; Singh S; Korra BT; Sharma S; Suresh V; Nishana M; Kumar R
    Brief Funct Genomics; 2024 Jun; ():. PubMed ID: 38864430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling mitochondrial and ribosomal gene deregulation and tumor microenvironment dynamics in acute myeloid leukemia.
    Ma C; Hao Y; Shi B; Wu Z; Jin D; Yu X; Jin B
    Cancer Gene Ther; 2024 May; ():. PubMed ID: 38806621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the RNA Expression and the DNA Methylation of Estrogen Receptor Genes in Normal and Malignant Human Tissues.
    Rong J; Xie X; Niu Y; Su Z
    Curr Issues Mol Biol; 2024 Apr; 46(4):3610-3625. PubMed ID: 38666956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New prognostic markers in acute myeloid leukemia: perspective from the clinic.
    Foran JM
    Hematology Am Soc Hematol Educ Program; 2010; 2010():47-55. PubMed ID: 21239770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
    Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
    Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.
    Paschka P; Schlenk RF; Gaidzik VI; Habdank M; Krönke J; Bullinger L; Späth D; Kayser S; Zucknick M; Götze K; Horst HA; Germing U; Döhner H; Döhner K
    J Clin Oncol; 2010 Aug; 28(22):3636-43. PubMed ID: 20567020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia.
    Zhong F; Yao F; Jiang J; Yu X; Liu J; Huang B; Wang X
    Inflamm Res; 2024 Mar; 73(3):329-344. PubMed ID: 38195768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia.
    Li D; Wu X; Cheng C; Liang J; Liang Y; Li H; Guo X; Li R; Zhang W; Song W
    Front Immunol; 2023; 14():1290968. PubMed ID: 38022627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
    Marcucci G; Maharry K; Radmacher MD; Mrózek K; Vukosavljevic T; Paschka P; Whitman SP; Langer C; Baldus CD; Liu CG; Ruppert AS; Powell BL; Carroll AJ; Caligiuri MA; Kolitz JE; Larson RA; Bloomfield CD
    J Clin Oncol; 2008 Nov; 26(31):5078-87. PubMed ID: 18809607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking the potential: A novel prognostic index signature for acute myeloid leukemia.
    Zhang LQ; Liang YC; Wang JX; Zhang J; La T; Li QZ
    Comput Biol Med; 2024 May; 173():108396. PubMed ID: 38574529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AML.
    Masarova L; Kantarjian H; Garcia-Mannero G; Ravandi F; Sharma P; Daver N
    Adv Exp Med Biol; 2017; 995():73-95. PubMed ID: 28321813
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.